PRF Technologies (PRFX) Total Liabilities (2019 - 2025)
PRF Technologies' (PRFX) quarterly Total Liabilities came in at $2.7 million in Q4 2025, little changed YoY from $2.7 million in Q4 2024, and little changed on a QoQ basis from $2.7 million in Q2 2025.
PRF Technologies (PRFX) Total Liabilities (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Total Liabilities data on file, last reported at $2.7 million in Q4 2025.
- Quarterly Total Liabilities changed 0.26% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (changed 0.26% YoY) and the FY2025 annual result came in at $2.7 million, changed 0.26% from the prior year.
- Total Liabilities held at $2.7 million in Q4 2025, from $2.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $21.4 million in Q1 2021 to a low of $787000.0 in Q2 2022.
- A 5-year average of $3.1 million and a median of $1.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities tumbled 95.3% — and 2024, when it soared 283.32%.
- Tracing PRFX's Total Liabilities over 5 years: stood at $991000.0 in 2021, then surged by 31.89% to $1.3 million in 2022, then soared by 37.72% to $1.8 million in 2023, then jumped by 50.06% to $2.7 million in 2024, then climbed by 0.26% to $2.7 million in 2025.
- The last three Total Liabilities figures came in at $2.7 million (Q4 2025), $2.7 million (Q2 2025), and $2.7 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 787,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 991,000.00 |
| Sep 30, 2021 | 856,000.00 |
| Jun 30, 2021 | 833,000.00 |
| Mar 31, 2021 | 21.35 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Jun 30, 2020 | 838,000.00 |
| Dec 31, 2019 | 1.16 Mn |